Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | CASR | P41180 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28445716 | 0.89 | ESR1 (0.46) | AOC3LMNACYP3A4CHRM2HTR1A | |
| SCHEMBL8101515 | 0.87 | POLB (0.47) | AOC3TAAR1LMNARIPK1OPRM1 | |
| SCHEMBL8095531 | 0.85 | ALDH1A1 (0.43) | OPRM1HTR2APOLBMEN1ALDH1A1 | |
| SCHEMBL8067118 | 0.84 | TAAR1 (0.40) | AOC3TAAR1LMNARIPK1CYP3A4 | |
| SCHEMBL8093469 | 0.84 | ALDH1A1 (0.45) | OPRM1KCNH2HTR2APOLBMEN1 | |
| SCHEMBL1293117 | 0.81 | LMNA (0.50) | AOC3TAAR1LMNACHRM2CHRM1 | |
| SCHEMBL5696505 | 0.80 | TRPA1 (0.55) | TAAR1LMNARIPK1ADRA2ATRPA1 | |
| SCHEMBL7737682 | 0.79 | TAAR1 (0.43) | AOC3TAAR1LMNARIPK1ADRA2A | |
| SCHEMBL17592400 | 0.78 | ACP3 (0.46) | CYP3A4SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL7531733 | 0.78 | AOC3 (0.59) | AOC3LMNACYP3A4CHRM2ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6967229-B2 | Carbon-carbon initiators for use in golf balls | ACUSHNET COMPANY (US) | 2005-11-22 | — | — | US | claimed |
| US-20050009992-A1 | Carbon-carbon initiators for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2005-01-13 | — | — | US | claimed |
| US-10221191-B2 | Compounds for the treatment of cancer and inflammatory disease | SHY Therapeutics LLC | 2019-03-05 | — | — | US | disclosed |
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC | 2017-06-22 | — | — | US | disclosed |
| US-9056227-B2 | Golf ball comprising a core having a shallow hardness gradient | ACUSHNET COMPANY (US) | 2015-06-16 | — | — | US | disclosed |
| US-8968117-B2 | Dual-core comprising zero gradient center and positive gradient outer core layer | ACUSHNET COMPANY (US) | 2015-03-03 | — | — | US | disclosed |
| US-20130109506-A1 | GOLF BALL COMPRISING A CORE HAVING A SHALLOW HARDNESS GRADIENT | ACUSHNET COMPANY (US) | 2013-05-02 | — | — | US | disclosed |
| US-20130109504-A1 | DUAL-CORE COMPRISING ZERO GRADIENT CENTER AND POSITIVE GRADIENT OUTER CORE LAYER | ACUSHNET COMPANY (US) | 2013-05-02 | — | — | US | disclosed |
| US-6967229-B2 | Carbon-carbon initiators for use in golf balls | ACUSHNET COMPANY (US) | 2005-11-22 | — | — | US | disclosed |
| US-20050009992-A1 | Carbon-carbon initiators for use in golf balls | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2005-01-13 | — | — | US | disclosed |
| EP-0717098-B1 | A refrigerating machine oil and a fluid composition for use in a refrigerating machine | NIPPON MITSUBISHI OIL CORP (JP) | 2004-01-21 | — | — | EP | disclosed |
| EP-0708077-B1 | Diamino compounds and methods for preparing them | CHISSO CORP (JP) | 2000-12-27 | — | — | EP | disclosed |
| US-5817251-A | AROMATIC HYDROCARBON LUBRICANT | NIPPON OIL CO., LTD. (JP) | 1998-10-06 | — | — | US | disclosed |
| US-5663440-A | Diamino compounds and methods for preparing them | CHISSO CORPORATION (JP) | 1997-09-02 | — | — | US | disclosed |
| EP-0717098-A2 | A refrigerating machine oil and a fluid composition for use in a refrigerating machine | NIPPON OIL CO. LTD. (JP) | 1996-06-19 | — | — | EP | disclosed |
| EP-0708077-A1 | Diamino compounds and methods for preparing them | CHISSO CORPORATION (JP) | 1996-04-24 | — | — | EP | disclosed |
| EP-0281162-A2 | Method for improving the electrical insulating characteristics of a fraction, electrical insulating substance, and electrical appliances containing the same | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1988-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221191-B2 | Compounds for the treatment of cancer and inflammatory disease | MAPK6, MAP3K6, MAPK4 | AOC3 4229/4885TAAR1 3699/4885LMNA 3509/4885 |
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | MAPK6, MAP3K6, MAPK4 | AOC3 4229/4885TAAR1 3699/4885LMNA 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.